EXACT SCIENCES CORP(EXAS)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2025-12-31.

EXACT SCIENCES CORP (EXAS) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores EXAS at 53.3/100 on a 32-signal composite quality model, placing it at rank #1,293 of 2,856 stocks — the top half of the AI-ranked universe. EXAS scores in the top quartile across earnings quality (85.1). Areas of concern include balance sheet strength (26.1) and profitability (33.8), which score below median versus the broader universe. Shareholder dilution risk is elevated at 21.8/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q4 2025), EXACT SCIENCES CORP reports quarterly revenue of $878.4M, net income of $-86.0M, an operating margin of -9.4%. Top institutional holders of EXAS by reported 13-F value include LINDEN ADVISORS, Weiss Asset Management, UBS OCONNOR, based on the most recent SEC filings. EXAS trades on the Nasdaq exchange and files with the SEC under CIK 1124140. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate EXAS daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for EXACT SCIENCES CORP directly from SEC EDGAR.